Home
Conditions
Neoplasms, Plasma Cell

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

2,606 public trials 547 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Completed

Family Caregiver Ambassador Support for Family Caregivers of Patients With Hematological Disease

NCT04039100

Conditions: Blood Protein Disorders, Bone Marrow Transplantation, Cardiovascular Diseases, +17 more
Locations: Rigshospitalet Copenhagen, Østerbro, Denmark

View Trial Details

Completed

Impact of COVID-19 After Autologous Hematopoietic Stem Cell Transplantation in Sweden

NCT04760184

Conditions: Blood Protein Disorders, COVID-19, Cardiovascular Diseases, +32 more
Locations: Uppsala Universitet Uppsala, Sweden

View Trial Details

Completed

Study of the Combination of Panobinostat and Carfilzomib in Patients With Relapsed/Refractory Multiple Myeloma

NCT01496118

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Colorado Blood Cancer Institute Denver, Colorado, United States

Florida Cancer Specialists South Fort Myers, Florida, United States

Woodlands Medical Specialists Pensacola, Florida, United States

Florida Cancer Specialists North St. Petersburg, Florida, United States

View all 13 locations

View Trial Details

Completed

A Dose Escalation Study of LNA-i-Mir-221 for Cancer Treatment

NCT04811898

Conditions: Adenocarcinoma, Advanced Solid Tumor, Blood Protein Disorders, +24 more
Locations: Center for Phase I Clinical Studies in Medical Oncology and Oncohematology - Translational Medical Oncology Unit, AOU MaterDomini and Magna Graecia University Catanzaro, Italy

View Trial Details

Completed

Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis

NCT01078454

Conditions: Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +11 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

The Medical Center of Aurora Aurora, Colorado, United States

Boulder Community Hospital Boulder, Colorado, United States

View all 209 locations

View Trial Details

Completed

Quality Assurance of Secondary Immunodeficiencies (SID) in CLL/MM Patients

NCT04172467

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +22 more
Locations: Privatärztliche Praxis; Innere Medizin, Hämatologie, Internistische Onkologie Kaiserslautern, Germany

View Trial Details

Completed

Evaluation of Safety of Pomalidomide in Combination With Dexamethasone (Low Dose) in Patients With Refractory or Relapsed and Refractory Multiple Myeloma

NCT01712789

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations: Medical University of Graz Graz, Austria

Medizinische Universitat Innsbruck Innsbruck, Austria

Wilhelminenspital Vienna Vienna, Austria

Medical University of Vienna Vienna, Austria

View all 112 locations

View Trial Details

Completed

Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies

NCT02145403

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +25 more
Locations: University of Michigan Hospital Ann Arbor, Michigan, United States

View Trial Details

Completed

Screening for Systemic Amyloidosis Via the Ligamentum Flavum

NCT03923920

Conditions: Alzheimer Disease, Amyloid, Amyloidosis, +26 more
Locations: Cleveland Clinic Cleveland, Ohio, United States

View Trial Details

Completed

Cardiac Amyloidosis Screening at Trigger Finger Release

NCT03886155

Conditions: Amyloidosis, Amyloidosis, Hereditary, Transthyretin-Related, Immune System Diseases, +18 more
Locations: Cleveland Clinic Cleveland, Ohio, United States

View Trial Details

Neoplasms, Plasma Cell

Neoplasms, Plasma Cell trial results

Related conditions